ArielAnnNelsonMD

Physician

Dr. Nelson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
9200 W Wisconsin Ave
# Clcc
Milwaukee, WI 53226
Phone+1 414-805-0509

Fax+1 414-805-6808

Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 2013 - 2016
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2013

PubMed

38 citations
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.
Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos, Natalie J. Miller, Lucia Carril-Ajuria
European Urology Oncology. 2021-06-01
7 citations
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.
Rafee Talukder, Dimitrios Makrakis, Genevieve Ihsiu Lin, Leonidas N Diamantopoulos, Scott Dawsey
Clinical Genitourinary Cancer. 2022-12-01
25 citations
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study.
Natalie J. Miller, Ali Raza Khaki, Leonidas Nikolaos Diamantopoulos, Mehmet Asim Bilen, Victor Sacristan Santos
The Journal of Urology. 2020-01-23

Lectures

Phase II study of eribulin mesylate for treatment of CNS metastases (mets) in metastatic breast cancer (mBC).
2019 ASCO Annual Meeting - 6/1/2019
Association of early bone metastases and outcomes of the bone predominant metastatic urothelial carcinoma (BP mUC) phenotype.
2019 ASCO Annual Meeting - 6/1/2019